Day Lucy
Chief Financial Officer
Day Lucy has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Feb 23, 2026.
On the most recent filing, Day Lucy is listed as Chief Financial Officer at AN2 Therapeutics, Inc. Inside the rolling window, Day Lucy reported no open-market purchases and 2 open-market sales totaling $9K in ANTX. The largest disclosed transaction in the window is a sale of 5,512 ANTX shares on Jan 6, 2026, worth $6K.
Companies traded
Other insiders at ANTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Day Lucy made?
Day Lucy has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Day Lucy trade?
Day Lucy has filed SEC Form 4 disclosures for 1 company, including ANTX.
When was Day Lucy's most recent SEC Form 4 filing?
Day Lucy's most recent SEC Form 4 filing on Tracefour is dated Feb 23, 2026.
What is Day Lucy's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Day Lucy is listed as Chief Financial Officer.
What is Day Lucy's total buy and sell value in the current window?
Inside the rolling retention window, Day Lucy bought $0 and sold $9K based on SEC Form 4 filings.
What was Day Lucy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,512 ANTX shares on 2026-01-06, worth $6K, per SEC Form 4 filings.